Aller au contenu principal
Accès ouvert déclaré 2026 article

Cumulative live birth after unstimulated in vitro maturation versus conventional in vitro fertilization (IVF) in women with polycystic ovary syndrome: a 36-month retrospective matched cohort study

1Citations signalées, ce qui n’est pas une note de qualité
7Institutions déclarées
3Pays d’affiliation déclarés

Rattachement africain : cn, tw, ro. Niveau de preuve : code pays fourni par la source.

Le résumé fourni par la source

BACKGROUND: Polycystic ovary syndrome (PCOS) is characterized by heterogeneous ovarian responsiveness and a heightened risk of ovarian hyperstimulation syndrome (OHSS) during gonadotropin stimulation. Strictly unstimulated in vitro maturation (IVM) avoids ovarian stimulation and may reduce treatment burden; however, long-term cumulative live birth outcomes remain insufficiently defined, especially across baseline ovarian phenotypes. METHODS: This retrospective matched cohort study included women aged 20–42 years with PCOS, diagnosed by the Rotterdam criteria, treated at a university-affiliated fertility center between January 2010 and December 2022 (follow-up through December 2023). Women undergoing unstimulated IVM (n = 545) were matched 1:3 by age and BMI to women undergoing conventional in vitro fertilization (IVF) using a GnRH antagonist protocol (n = 1,635). The primary outcome was the 36-month cumulative live birth rate (CLBR) per initiated oocyte retrieval cycle. Secondary outcomes included implantation and live birth after the first transfer (fresh vs. frozen), OHSS, and obstetric/perinatal outcomes. Odds ratios (ORs) were calculated for the freeze-all subset. RESULTS: The 36-month CLBR per initiated retrieval cycle was significantly lower with IVM than IVF (22.20% vs. 47.95%; P < 0.001). CLBR/embryo transfer cycles was also lower with IVM (31.43% vs. 50.19%; P < 0.001). Implantation was lower in the IVM group after fresh transfer (22.94% vs. 29.45%; P = 0.005) but higher after frozen embryo transfer (43.86% vs. 32.62%; P = 0.007). Live birth after the first fresh transfer was lower with IVM (25.96% vs. 33.20%; P = 0.029), whereas after the first frozen transfer, live birth was comparable (33.33% vs. 36.61%; P = 0.486). No severe OHSS occurred in the IVM group, compared to 0.98% in IVF cycles. In women with AFC ≥ 24, live birth after the first frozen transfer was similar between groups (OR 0.99, 95% CI 0.57–1.72). Obstetric and neonatal outcomes were broadly comparable. CONCLUSIONS: Unstimulated IVM in PCOS women yielded a lower 36-month CLBR compared to IVF, primarily due to lower embryo yield. IVM eliminated OHSS and achieved comparable live birth rates following the FET, particularly in women with high AFC. These findings advocate for a ‘freeze-all’ IVM strategy to optimize both safety and reproductive outcomes in this high-risk population. CLINICAL TRIAL NUMBER: Not applicable.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.

Le contrôle bibliographique ouvert

DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.

Titre Crossref
Cumulative live birth after unstimulated in vitro maturation versus conventional in vitro fertilization (IVF) in women with polycystic ovary syndrome: a 36-month retrospective matched cohort study
Date Crossref
14/04/2026
Éditeur
Springer Science and Business Media LLC
Type
journal-article

Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.

Où se fait cette recherche

  • Peking University Department of Obstetrics and Gynecology pays non établi dans la notice
    Université ou école supérieure
  • Peking University Third Hospital pays non établi dans la notice
    Établissement de santé
  • Chinese Academy of Medical Sciences & Peking Union Medical College pays non établi dans la notice
    Université ou école supérieure
  • China Medical University Department of Obstetrics and Gynecology pays non établi dans la notice
    Université ou école supérieure
  • China Medical University Hospital pays non établi dans la notice
    Établissement de santé
  • Ministry of Education pays non établi dans la notice
    Organisme public
  • Ministry of Education of the People's Republic of China pays non établi dans la notice
    Organisme public
  • Beijing Key Laboratory of Reproductive Endocrinology and Assisted Reproductive Technology pays non établi dans la notice
    Structure de recherche
  • Research Units of Comprehensive Diagnosis and Treatment of Oocyte Maturation Arrest pays non établi dans la notice
    Structure de recherche

Department of Obstetrics and Gynecology — Peking University, Peking University Third Hospital et Chinese Academy of Medical Sciences & Peking Union Medical College, avec 6 autres affiliations.

Une affiliation ne permet pas de déduire la nationalité d’un auteur.

Les sujets associés

Ovarian function and disordersReproductive Biology and FertilityReproductive Health and Technologies

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.